{
  "ptid_time": "007_S_4620_2014-04-22",
  "img_path": "/data/qiuhui/data/adni/images/007_S_4620/2014-04-22/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 47,257 mm³, 22.7% above the reference mean. With a Z-score of 0.54 (70.7th percentile), this represents normal volume ; hippocampal volume measures 6,409 mm³, 15.2% below the reference mean. With a Z-score of -1.48 (6.9th percentile), this represents mild atrophy; whole brain volume measures 956,595 mm³, 11.4% below the reference mean. With a Z-score of -1.48 (7.0th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,128 mm³, 23.7% below the reference mean. With a Z-score of -1.61 (5.4th percentile), this represents moderate atrophy; fusiform gyrus volume measures 17,256 mm³, 8.4% below the reference mean. With a Z-score of -0.72 (23.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 21,179 mm³, 0.7% below the reference mean. With a Z-score of -0.07 (47.3th percentile), this represents normal volume . ",
  "text_data": "Age is 79.1 years. Gender is Male. Education: 19 years. MMSE: 30.0. MoCA: 30.0. Logical Memory: 14.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.18 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild to moderate atrophy in the hippocampus and entorhinal cortex, which are key regions affected in Alzheimer's disease, while other regions remain largely normal. However, cognitive scores (MMSE, MoCA) are intact, and amyloid PET (AV45) is normal, suggesting no significant clinical impairment or amyloid pathology.  \n\n**Diagnosis:** **CN (Cognitively Normal)**  \n**Confidence:** **Medium** (due to structural atrophy without cognitive or biomarker evidence of progression)",
  "timestamp": "2025-07-25T22:04:40.164144"
}